GORE® VIABAHN® Endoprosthesis
- Home / GORE® VIABAHN® Endoprosthesis / News /
Gore Joins Vascular and Endovascular Leaders in Honoring 2012 Pioneers in Performance in Europe
16 April 2012 - Leading Practitioners and Researchers from Europe Commended for Expanding Treatment Options for At-Risk Patients
16 April 2012 - Leading Practitioners and Researchers from Europe Commended for Expanding Treatment Options for At-Risk Patients
Nominees Announced for 2011-2012 Pioneers in Performance Awards for the United States; Online Voting Opens at www.PioneersInPerformance.com
16 November 2011 - Awards Program Sponsored by W. L. Gore & Associates Honors Medical Specialists Advancing Therapy and Improving Patient and Clinical Performance Through Active Collaboration
16 November 2011 - Awards Program Sponsored by W. L. Gore & Associates Honors Medical Specialists Advancing Therapy and Improving Patient and Clinical Performance Through Active Collaboration
Nominees Announced for 2011 Pioneers in Performance Awards for Europe; Online Voting Opens at www.PioneersInPerformance.com
11 April 2011 - Awards Program Sponsored by W. L. Gore & Associates Honors Medical Specialists Advancing Therapy and Improving Patient and Clinical Performance Through Active Collaboration
11 April 2011 - Awards Program Sponsored by W. L. Gore & Associates Honors Medical Specialists Advancing Therapy and Improving Patient and Clinical Performance Through Active Collaboration
Gore Reports First Patient Treated in Europe using the GORE® VIABAHN® Endoprosthesis with PROPATEN Bioactive Surface on a Lower Profile Delivery System
21 March 2011 - Lower profile delivery system provides more options for endoluminal bypass
21 March 2011 - Lower profile delivery system provides more options for endoluminal bypass
Gore Reports First Patient Treated in the US using GORE® VIABAHN® Endoprosthesis with Heparin Bioactive Surface on a Lower Profile Delivery System
21 March 2011 - Lower profile delivery system provides more options for endoluminal bypass
21 March 2011 - Lower profile delivery system provides more options for endoluminal bypass
Gore Announces FDA Approval of Next Evolution of GORE® VIABAHN® Endoprosthesis
17 February 2011 - Lower profile delivery system in the US provides more options for endoluminal bypass
17 February 2011 - Lower profile delivery system in the US provides more options for endoluminal bypass
Gore Announces European Availability of Next Evolution of GORE® VIABAHN® Endoprosthesis
19 January 2011 - Lower profile delivery system in Europe provides more options for endoluminal bypass
19 January 2011 - Lower profile delivery system in Europe provides more options for endoluminal bypass
Post-market Approval Study of GORE® VIABAHN® Endoprosthesis with Heparin Bioactive Surface for Lower Limb Vascular Disease Completes Patient Enrollment
23 September 2010 - Study Assesses Performance of Heparin Bioactive Surface
23 September 2010 - Study Assesses Performance of Heparin Bioactive Surface
Gore Receives CE Mark for Longer Length GORE® VIABAHN® Endoprosthesis
01 July 2010 - Longest stent-graft ever introduced in Europe for SFA endoluminal bypass
01 July 2010 - Longest stent-graft ever introduced in Europe for SFA endoluminal bypass
Vascular Surgeons Present Positive Study Results for the GORE PROPATEN® Vascular Graft and Updates to the GORE VIABAHN® Endoprosthesis
17 September 2009 - Physicians report new information at the Society for Vascular Surgery's annual meeting
17 September 2009 - Physicians report new information at the Society for Vascular Surgery's annual meeting